| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $209.0M | +86.0% |
| Cost of Revenue | $194.0M | +106.1% |
| Gross Profit | $15.1M | -17.6% |
| R&D Expense | $96.9M | +42.2% |
| SG&A Expense | $83.1M | +6.4% |
| Operating Income | -$731.8M | -263.2% |
| Pre-tax Income | -$741.8M | -174.8% |
| Income Tax | -$1.5M | +95.0% |
| Net Income | -$740.3M | -208.0% |
| EPS (Basic) | -$2.35 | -155.4% |
| EPS (Diluted) | -$2.35 | -155.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.3M | +17.3% |
| Short-term Investments | $108.2M | -47.1% |
| Accounts Receivable | $38.5M | -17.6% |
| Inventory | $91.7M | +40.3% |
| Current Assets | $336.4M | -16.3% |
| Total Assets | $754.3M | -45.7% |
| Current Liabilities | $83.4M | -19.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$181.5M | -17.1% |
| Capital Expenditures | $11.5M | +49.9% |
| Investing Cash Flow | $81.6M | +119.1% |
| Financing Cash Flow | $113.8M | -31.7% |
| Free Cash Flow | -$193.0M | -18.6% |
| Total Liabilities |
| $226.8M |
| +61.7% |
| Stockholders' Equity | $527.5M | -57.7% |